Explore more publications!

Oman Healthcare News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Oman Healthcare News.

Press releases published on April 17, 2026

Yuhua Zhang, PhD, Named Chairholder of the Carolyn and Chuck Miller Endowed Chair for Vision Research
Psyence BioMed Welcomes U.S. Executive Action to Advance Research into Ibogaine
Global Widget Celebrates 10 Years as a Leader in Premium Gummy Manufacturing
Omada Health Helps Members on GLP‑1s Lose More Fat, Preserve Muscle Mass, and Improve Mental Health, New Study Finds
Alps Group Appoints Former Ernst & Young Partner to Board of Directors, Strengthening Governance and Capital Markets Oversight
Wilcrest Pharma Awarded Outsourced Compounded Preparations Agreement with Premier, Inc.
Intelligent Bio Solutions Advances Upcoming FDA 510(k) Submission, Successfully Completes Penetration Testing with No Major Vulnerabilities Identified
Vaxart Announces Share Purchase Agreement for up to $25 Million with Lincoln Park Capital
SRx Health Solutions and EMJX Issue Letter to Shareholders from Eric M. Jackson
First Steps Developmental Services Expands Services in Woburn
Lexicon to Present Data at the American Academy of Neurology (AAN) Annual Meeting
Cogent Biosciences Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026
Lyra Therapeutics, Inc. Announces Intention to Voluntarily File Form 25 for Delisting from Nasdaq and Subsequent Deregistration with the SEC
Medicus Pharma Submits Orphan Drug Designation Application to U.S. FDA for SkinJect® in Gorlin Syndrome
Repligen Opens European Training & Innovation Center in Breda, Expanding Global Customer Support Network
Alterity Therapeutics Appoints Highly Experienced Biotech Executive Ann Cunningham to its Board of Directors
BioXcel Therapeutics Announces Virtual Event to Discuss Commercial Launch Plan Based on Market Opportunity Assessment for IGALMI® in the At-Home Setting
Upstream Bio to Present New Data from Phase 2 VIBRANT Trial of Verekitug at the ATS 2026 International Conference
Yaqrit Phase 2a data, clinical consensus boost YAQ007 and YAQ006 in Hepatic Encephalopathy
Invest in the Future of Clean Energy Drinks: US Capital Global Securities Announces $10 Million Offering for G.O.A.T. Fuel

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions